Disappearance rate of insulin antibodies after discontinuing insulin treatment in 42 type 2 (non-insulin-dependent) diabetic patients
- PMID: 6397385
- DOI: 10.1007/BF00276974
Disappearance rate of insulin antibodies after discontinuing insulin treatment in 42 type 2 (non-insulin-dependent) diabetic patients
Abstract
The disappearance rate of insulin antibodies was studied after cessation of insulin treatment which had been given for 3 months to 6 years in 42 Type 2 (non-insulin-dependent) diabetic patients. Insulin antibodies were measured before and 15 days after interruption of insulin treatment, and every 30 days until the disappearance of insulin antibodies. The mean +/- SD value of insulin binding in the entire group before the interruption of insulin treatment was 32 +/- 14%. There was no relationship between the antibody level at that time and the duration of insulin treatment. However, the insulin antibody level was significantly higher in 17 diabetic patients on an insulin dose of greater than 20 U/day (p less than 0.02) than in 25 on an insulin dose of less than 20 U/day (39 +/- 13% versus 28 +/- 12%). A positive correlation was found between initial insulin binding and the time required for it to fall below 10% (r = 0.74). Antibodies were absent 60 days after discontinuing insulin treatment in eight of ten subjects presenting with initial binding of less than 20%. In contrast, in only two of 12 patients with an initial binding of greater than 40% were insulin antibodies detectable 150 days after discontinuation of insulin therapy. Disappearance of insulin antibodies sometimes took up to 1 year and occasionally even more than 2 years.
Similar articles
-
Insulin antibodies in non-insulin-dependent diabetes mellitus: effect of treatment with semisynthetic human insulin.Clin Ther. 1989 Mar-Apr;11(2):268-77. Clin Ther. 1989. PMID: 2660998
-
Comparative study of insulin antibodies in diabetic patients with primary insulin-dependence (type I) and secondary insulin-dependence (type II).Med Interne. 1989 Oct-Dec;27(4):303-11. Med Interne. 1989. PMID: 2694321
-
Immunologic aspects of human proinsulin therapy.Diabetes. 1988 Mar;37(3):276-80. doi: 10.2337/diab.37.3.276. Diabetes. 1988. PMID: 3286327 Clinical Trial.
-
Insulin--binding antibodies in Nigerian diabetic patients.West Afr J Med. 1990 Oct-Dec;9(4):291-4. West Afr J Med. 1990. PMID: 2083207
-
Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody.Taiwan Yi Xue Hui Za Zhi. 1989 Apr;88(4):346-51. Taiwan Yi Xue Hui Za Zhi. 1989. PMID: 2677227 Clinical Trial.
Cited by
-
Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.Endocr Connect. 2018 Jan;7(1):R47-R55. doi: 10.1530/EC-17-0309. Epub 2017 Dec 12. Endocr Connect. 2018. PMID: 29233817 Free PMC article. Review.
-
Analysis of the Outcomes of 73 Patients with Exogenous Positive Insulin Anti-Body.Diabetes Metab Syndr Obes. 2022 Nov 15;15:3543-3553. doi: 10.2147/DMSO.S386436. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 36411789 Free PMC article.
-
A longitudinal study of insulin antibodies and anti-insulin cytotoxicity in type I diabetes mellitus.Acta Diabetol Lat. 1987 Oct-Dec;24(4):271-82. doi: 10.1007/BF02742958. Acta Diabetol Lat. 1987. PMID: 3501924
-
Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study.Diabetologia. 1987 Sep;30(9):681-90. doi: 10.1007/BF00296989. Diabetologia. 1987. PMID: 3123298
-
Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study.J Diabetes Res. 2019 Mar 18;2019:7304140. doi: 10.1155/2019/7304140. eCollection 2019. J Diabetes Res. 2019. PMID: 31687408 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical